Translational Immunotherapeutics: Chemoimmunotherapy for Malignant Pleural Mesothelioma

od Adusumilli, Prasad S.
Izdano u Cancer (2014)

Spread Through Alveolar Spaces (STAS): An Airborne Invasion in Pulmonary Adenocarcinomas

od Adusumilli, Prasad S.
Izdano u J Thorac Cardiovasc Surg (2016)

Is spread through alveolar spaces, the newly recognized pattern of invasion, a potential game changer in lung adenocarcinoma?

od Bains, Sarina, Adusumilli, Prasad S.
Izdano u Ann Transl Med (2015)

Competing risks analysis in the prognostic assessment of patients undergoing lung resection

od Eguchi, Takashi, Adusumilli, Prasad S.
Izdano u J Thorac Dis (2017)

Co-inhibitory receptor programmed cell death protein 1 targets co-stimulatory CD28

od Chicaybam, Leonardo, Adusumilli, Prasad S.
Izdano u Transl Cancer Res (2017)

Mesothelin-targeted immunotherapies for malignant pleural mesothelioma

od Villena-Vargas, Jonathan, Adusumilli, Prasad S.
Izdano 2012

Next frontiers in CAR T-cell therapy

od Brown, Christine E, Adusumilli, Prasad S
Izdano u Mol Ther Oncolytics (2016)

Mesothelin-Targeted CARs: Driving T cells to Solid Tumors

od Morello, Aurore, Sadelain, Michel, Adusumilli, Prasad S.
Izdano u Cancer Discov (2015)

Immunotherapy for malignant pleural mesothelioma: current status and future directions

od Dozier, Jordan, Zheng, Hua, Adusumilli, Prasad S.
Izdano u Transl Lung Cancer Res (2017)

Commentary: Return to intended radiation therapy: criteria for resection?

od Dux, Joseph, Grosser, Rachel, Adusumilli, Prasad S.
Izdano u J Thorac Cardiovasc Surg (2019)

Prognostic value of the immune microenvironment in lung adenocarcinoma

od Kadota, Kyuichi, Nitadori, Jun-ichi, Adusumilli, Prasad S.
Izdano 2013

Competing risks and cancer-specific mortality: why it matters

od Tan, Kay See, Eguchi, Takashi, Adusumilli, Prasad S.
Izdano u Oncotarget (2017)

Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survival

od Tan, Kay See, Eguchi, Takashi, Adusumilli, Prasad S
Izdano u Clin Epidemiol (2019)

Opioid use and abuse following video-assisted thoracic surgery (VATS) or thoracotomy lung cancer surgery

od Nobel, Tamar B., Adusumilli, Prasad S., Molena, Daniela
Izdano u Transl Lung Cancer Res (2019)

Commentary: Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice

od Hocine, Hocine Rachid, Quach, Hue T., Adusumilli, Prasad S.
Izdano u Front Immunol (2020)

Advances in Experimental and Translational Research in the Treatment of Hepatocellular Carcinoma

od Kidner, Travis, Dai, Menghua, Adusumilli, Prasad S., Fong, Yuman
Izdano 2008

Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy

od Takahashi, Yusuke, Eguchi, Takashi, Bains, Sarina, Adusumilli, Prasad S.
Izdano u Ann Transl Med (2016)

CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy

od Chen, Nan, Morello, Aurore, Tano, Zachary, Adusumilli, Prasad S.
Izdano u Oncoimmunology (2016)

Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

od Grosser, Rachel, Cherkassky, Leonid, Chintala, Navin, Adusumilli, Prasad S.
Izdano u Cancer Cell (2019)

Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence

od de Biasi, Andreas R., Villena-Vargas, Jonathan, Adusumilli, Prasad S.
Izdano u Clin Cancer Res (2014)